BIOlogics in Severe Nasal POlyposis SurvEy.: a French Registry

NCT06501807 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

900

Enrollment

OTHER

Sponsor class

Conditions

Rhinosinusitis Chronic
Nasal Polyps

Interventions

DRUG: Biologic treatments available in Chronic Rhinosinusitis with Nasal Polyps (dupilumab, mepolizumab and benralizumab according to their marketing approval).

Sponsor

University Hospital, Lille